Edwards Lifesciences Corp — Director's Dealing 2012

Jul 27, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-07-25

Reporting Person: BOBO DONALD E JR (CVP, Heart Valve Therapy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-25	Common Stock	M	44000.0000	$24.4200	Acquired	65022.0000	Direct
2012-07-25	Common Stock	S	44000.0000	$105.0300	Disposed	21022.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-25	Employee Stock Option (Right to Acquire)	$24.4200	M	44000.0000	Disposed	2014-05-09	Common Stock (44000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4466.0000	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 28, 2011.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.

F3: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.